Clinical Trial Update: Efficacy and Safety of a Pentavalent Rotavirus Vaccine (BRV-PV) Against Severe Rotavirus Gastroenteritis in Niger [Phase 3]

View source ↗

Summary

Phase 3 trial update on BRV-PV pentavalent rotavirus vaccine assessing efficacy and safety against severe rotavirus gastroenteritis in Niger.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotavirus Gastroenteritis

Drugs mentioned

• BRV-PV

Snippet

Sponsor: Epicentre | Conditions: Severe Rotavirus Gastroenteritis | Phase 3 | Status: COMPLETED